Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3272686
Max Phase: Preclinical
Molecular Formula: C52H71N13O19
Molecular Weight: 1182.21
Molecule Type: Protein
Associated Items:
ID: ALA3272686
Max Phase: Preclinical
Molecular Formula: C52H71N13O19
Molecular Weight: 1182.21
Molecule Type: Protein
Associated Items:
Canonical SMILES: COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C52H71N13O19/c1-24(2)41(64-43(74)25(3)57-45(76)34(19-39(70)71)59-49(80)37(22-66)63-44(75)31(53)17-29-21-55-23-56-29)50(81)60-32(15-27-9-7-6-8-10-27)48(79)65-42(26(4)67)51(82)61-35(20-40(72)73)47(78)58-33(18-38(54)69)46(77)62-36(52(83)84-5)16-28-11-13-30(68)14-12-28/h6-14,21,23-26,31-37,41-42,66-68H,15-20,22,53H2,1-5H3,(H2,54,69)(H,55,56)(H,57,76)(H,58,78)(H,59,80)(H,60,81)(H,61,82)(H,62,77)(H,63,75)(H,64,74)(H,65,79)(H,70,71)(H,72,73)/t25-,26+,31-,32-,33-,34-,35-,36-,37-,41-,42-/m0/s1
Standard InChI Key: IKRJOCZQPDXJKG-DFRPDVENSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1182.21 | Molecular Weight (Monoisotopic): 1181.4989 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Bodanszky M, Henes JB, Yiotakis AE, Said SI.. (1977) Synthesis and pharmacological properties of the N-terminal decapeptide of the vasoactive intestinal peptide (VIP)., 20 (11): [PMID:915906] [10.1021/jm00221a019] |
Source(1):